AOAC SPIFAN Stakeholder Panel Meeting Book (March 14, 2019)

STAKEHOLDER PANEL ON INFANT FORMULA AND ADULT NUTRITIONALS (SPIFAN)

Gregory Noonan, U.S. FDA US Delegate to CCMAS

Dr. Gregory Noonan joined the US Food and Drug Administration in 2002 and is currently the Director of the Division of Bioanalytical Chemistry (DBC) in the Office of Regulatory Science. The Division of Bioanalytical Chemistry contains over 35 scientists performing research and developing analytical methods in numerous subject areas, including, toxic elements analysis, immunodiagnostic and DNA- based allergen detection, radionuclides, pesticide analysis, mycotoxin analysis, dietary supplements and botanicals, nutritional ingredients and cosmetics. Prior to becoming Director, Dr. Noonan was a Research Chemist in the Method Development Branch of the Division of Analytical Chemistry. His research focused on developing methods

for the determination of food additives, including indirect additives, and process induced contaminants. Dr. Noonan also serves as the US Delegate to the Codex Committee on Methods of Analysis and Sampling (CCMAS), where he chairs the Working Group on the Endorsement of Methods. Dr. Noonan received his PhD in Chemistry from Michigan State University in 1996. After graduation he worked for the Diagnostic Division of Abbott Laboratories, where he developed diagnostic immunoassays for Hepatitis A, B and C and HIV. After leaving Abbott Laboratories and prior to joining the FDA, he was a postdoctoral fellow in the Civil and Environmental Engineering department of the Massachusetts Institute of Technology, where he studied the fate and transport of polar, water soluble environmental contaminants.

Made with FlippingBook flipbook maker